# Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma

Source: https://onco.cc/trials/nct06861452/  
OnCo record `nct06861452` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial in pancreatic cancer, run by EIR Biotherapies s.r.l., now recruiting.

## Summary

Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma is a phase 1/2, interventional study registered as NCT06861452 by EIR Biotherapies s.r.l., with a registry enrolment figure of 9 participants, started 2025-06-25 and due to reach its primary completion in 2027-07-29. Interventions recorded: RR001. Conditions listed: Locally Advanced Pancreatic Adenocarcinoma. Primary outcome: Evaluation of Safety in terms of monitoring of systemic tolerance, Adverse Events (AEs) and severe AEs (SAEs) assess by CTCAE (Version 5.0). Pancreatic eligibility wording from the registry: "* Patients with confirmed pancreatic ductal adenocarcinoma classified as locally advanced pancreatic adenocarcinoma (LPAC)". Sites: Italy. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: SNIPER
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06861452
- Phase: 1/2
- Setting: RR001 in Combination With Chemotherapy for Patients With Locally Advanced Pancreatic Adenocarcinoma: Open-label, Non-randomized Dose Escalation Phase I/IIa Study
- Sponsor: EIR Biotherapies s.r.l.
- Enrolled: 9

## Sources

- ClinicalTrials.gov NCT06861452: https://clinicaltrials.gov/study/NCT06861452

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06861452.json